iCareDx, Inc. - NY New York, New York City 10017

iCareDx, Inc. entered the industry of In Vitro Diagnostics in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541711, which describes it as a In Vitro Diagnostics. For further clarification, the SIC classifies this business under the code 8731 and described it as a In Vitro Diagnostics. The business provides service to the BOTH market.

To acquire more information, please contact Bernard M. Peperstraete by calling (212) 972-0077 during business hours. You can also write to the business’ Headquarters at 369 Lexington Avenue, Fl26, New York City, New York NY 10017. You can also visit the company’s website at www.icaredx.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: iCareDx, Inc.
Representative: Bernard M. Peperstraete
Place of Business: 369 Lexington Avenue, Fl26, New York City, NY 10017
Contact Number: (212) 972-0077
Website: www.icaredx.com
Type of Service: In Vitro Diagnostics
SIC Number: 8731
NAICS Number: 541711
Locality: Headquarters
Market Type: B2B & B2C
Began: 2013
Income/Year: $0 to $49.999
Laborers: 1 to 4
Share This Company:

iCareDx, Inc. is a company operating from New York, New York providing professional In Vitro Diagnostics and relevant BOTH variables. It was founded in 2013 and registered with the SIC code 8731 as In Vitro Diagnostics, and with the NAICS code 541711 as In Vitro Diagnostics.

With a current employee count of 1 to 4, iCareDx, Inc. has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Bernard M. Peperstraete at (212) 972-0077 for related queries, or to locate its Headquarters using the coordinates 40.7603918,-73.980766.

The Headquarters can also be found at the street address 369 Lexington Avenue, Fl26 in New York City, New York 10017 and can be engaged online through the company website at www.icaredx.com, the company Twitter , and Facebook page .